-transparent.png){kind=logo}
The hypnotic activity of N3-phenacyluridine in 2.0 mumol/mouse by intracerebroventricular (i.c.v.) injection was 20 times stronger than that of known N3-benzyluridine. In 0.5 mumol/mouse, i.c.v., this compound strongly potentiated both pentobarbital- and diazepam-induced sleep as compared to N3-substituted uridines, including N3-benzyluridine. Furthermore, the compound caused motor incoordination as well as decreasing spontaneous activity in the same dose. These results indicate that among the N3-substituted uridines and related compounds previously reported, N3-phenacyluridine possesses potent depressant effects.
Related Publications
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
January 2003,
Research communications in molecular pathology and pharmacology,
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
October 1991,
Chemical & pharmaceutical bulletin,
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
August 2000,
Biological & pharmaceutical bulletin,
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
June 1986,
Research communications in chemical pathology and pharmacology,
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
January 1995,
Nucleic acids symposium series,
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
December 1999,
Chemical & pharmaceutical bulletin,
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
June 2000,
Xenobiotica; the fate of foreign compounds in biological systems,
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
September 1980,
Chemical & pharmaceutical bulletin,
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
January 1989,
Psychopharmacology,
I Yamamoto, and
J Kuze, and
T Kimura, and
K Watanabe, and
S Kondo, and
I K Ho
July 2014,
Annals of neurosciences,
